Search Results

You are looking at 1 - 1 of 1 items for

  • Author: Bhaven Chavan x
  • Refine by access: All content x
Clear All Modify Search
Jennifer D Spencer Clinical and Experimental Dermatology, Department of Biomedical Sciences, University of Bradford, Bradford BD7 1DP, UK
Institute for Pigmentary Disorders in association with EM Arndt University Greifswald, Germany and University of Bradford, Bradford BD7 1DP, UK
Biomedical Sciences, University of Bradford, Bradford BD7 1DP, UK

Search for other papers by Jennifer D Spencer in
Google Scholar
PubMed
Close
,
Bhaven Chavan Clinical and Experimental Dermatology, Department of Biomedical Sciences, University of Bradford, Bradford BD7 1DP, UK
Institute for Pigmentary Disorders in association with EM Arndt University Greifswald, Germany and University of Bradford, Bradford BD7 1DP, UK
Biomedical Sciences, University of Bradford, Bradford BD7 1DP, UK

Search for other papers by Bhaven Chavan in
Google Scholar
PubMed
Close
,
Lee K Marles Clinical and Experimental Dermatology, Department of Biomedical Sciences, University of Bradford, Bradford BD7 1DP, UK
Institute for Pigmentary Disorders in association with EM Arndt University Greifswald, Germany and University of Bradford, Bradford BD7 1DP, UK
Biomedical Sciences, University of Bradford, Bradford BD7 1DP, UK

Search for other papers by Lee K Marles in
Google Scholar
PubMed
Close
,
Sobia Kauser Clinical and Experimental Dermatology, Department of Biomedical Sciences, University of Bradford, Bradford BD7 1DP, UK
Institute for Pigmentary Disorders in association with EM Arndt University Greifswald, Germany and University of Bradford, Bradford BD7 1DP, UK
Biomedical Sciences, University of Bradford, Bradford BD7 1DP, UK

Search for other papers by Sobia Kauser in
Google Scholar
PubMed
Close
,
Hartmut Rokos Clinical and Experimental Dermatology, Department of Biomedical Sciences, University of Bradford, Bradford BD7 1DP, UK
Institute for Pigmentary Disorders in association with EM Arndt University Greifswald, Germany and University of Bradford, Bradford BD7 1DP, UK
Biomedical Sciences, University of Bradford, Bradford BD7 1DP, UK

Search for other papers by Hartmut Rokos in
Google Scholar
PubMed
Close
, and
Karin U Schallreuter Clinical and Experimental Dermatology, Department of Biomedical Sciences, University of Bradford, Bradford BD7 1DP, UK
Institute for Pigmentary Disorders in association with EM Arndt University Greifswald, Germany and University of Bradford, Bradford BD7 1DP, UK
Biomedical Sciences, University of Bradford, Bradford BD7 1DP, UK

Search for other papers by Karin U Schallreuter in
Google Scholar
PubMed
Close

The human skin holds the full machinery for pro-opiomelanocortin processing. The α-melanocyte-stimulating hormone (α-MSH)/melanocortin-1-receptor cascade has been implicated as a major player via the cAMP signal in the control of melanogenesis. Only very recently the β-endorphin/μ-opiate receptor signal has been added to the list of regulators of melanocyte dendricity and melanin formation. In this context it was reported that (6R)-l-erythro-5,6,7,8-tetrahydrobiopterin (6BH4) can act as an allosteric inhibitor of tyrosinase, the key enzyme in melanogenesis, and this inhibition is reversible by both α- and β-MSH. It was also shown earlier that 7BH4, the isomer of 6BH4, is twice as active in this inhibition reaction. However, as yet it is not known whether 7BH4 is indeed present in loco in the melanosome. We here provide evidence that this isomer is present in this organelle in a concentration range up to 50 × 10−6 M. Determination of β-MSH in melanosomal extracts yielded 10 pg/mg protein. Moreover, we demonstrate reactivation of the 7BH4/tyrosinase inhibitor complex by β-MSH, whereas α-MSH failed to do so. Furthermore, we show intra-melanosomal l-dopa formation from dopachrome by 7BH4 in a concentration range up to 134 × 10−6 M. Based on these results, we propose a new receptor-independent mechanism in the control of tyrosinase/melanogenesis by β-MSH and the pterin 7BH4.

Free access